000 01328 a2200409 4500
005 20250513044259.0
264 0 _c19950131
008 199501s 0 0 fre d
022 _a0003-9683
040 _aNLM
_beng
_cNLM
100 1 _aGallet, M
245 0 0 _a[Informed consent, what information is left after a therapeutic trial?].
_h[electronic resource]
260 _bArchives des maladies du coeur et des vaisseaux
_cJan 1994
300 _a39-45 p.
_bdigital
500 _aPublication Type: Clinical Trial; English Abstract; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aClinical Trials as Topic
_xlegislation & jurisprudence
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInformed Consent
650 0 4 _aMale
650 0 4 _aMexiletine
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aPatient Compliance
650 0 4 _aPhysician-Patient Relations
650 0 4 _aPlacebos
650 0 4 _aSurveys and Questionnaires
700 1 _aAupetit, J F
700 1 _aServan, E
700 1 _aLestaevel, M
700 1 _aLopez, M
700 1 _aChassoux, G
773 0 _tArchives des maladies du coeur et des vaisseaux
_gvol. 87
_gno. 1
_gp. 39-45
999 _c7810507
_d7810507